Literature DB >> 21351703

Synchronous squamous esophageal carcinoma and urothelial renal cancer.

I D Vilcea1, I Vasile, P Tomescu, C Mirea, A M Vilcea, L Stoica, C Mesina, T Dumitrescu, M Cheie, M A Enache.   

Abstract

Synchronous development of a second primary cancer in patients with esophageal squamous cell carcinoma was reported in 2.73%-11% of the cases. Although the synchronous association between esophageal and renal cancer is very rare, an increasingly number of cases is reported in medical literature. This study's aim is to report a case of synchronous esophageal squamous cell carcinoma and an urothelial carcinoma of the right kidney. Patient G.D. was admitted in our clinic with esophageal cancer diagnosis; during the preoperative work-up protocol, an asymptomatic right renal mass was discovered. A nephroureteroscopy with biopsy was performed and the urothelial renal cancer diagnosis was established. The patient is proposed for seriate surgery: nephroureterectomy on the first stage, then esophagectomy with gastric reconstruction was performed. Postoperative evolution was unfavourable, patient being finally discharged, on his request, with severely altered status.

Entities:  

Mesh:

Year:  2010        PMID: 21351703

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  2 in total

1.  Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging?

Authors:  Azka Ali; William P Skelton; Neeka N Akhavan; Thu-Cuc Nguyen; Zachary A Taylor; Tabitha Townsend; Prajwol Pathak; Nalini Hasija; Li Li; Jacqueline Indrisek; Scott Watson; Isis Nixon; Nam H Dang; Robert Zlotecki; Paul Crispen; Robert Allan; Patricia Abbitt; Long H Dang
Journal:  Case Rep Oncol Med       Date:  2016-11-22

2.  Case report: Quadruple primary malignant neoplasms including esophageal, ureteral, and lung in an elderly male.

Authors:  Long Wan; Feng-Yan Yin; Hai-Hua Tan; Li Meng; Jian-Hua Hu; Bao-Rong Xiao; Zhao-Feng Zhu; Ning Liu; Huan-Peng Qi
Journal:  Open Life Sci       Date:  2022-09-16       Impact factor: 1.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.